Subtypes of insomnia disorders and effectiveness of cognitive behavioral therapy of insomnia
Authors | |
---|---|
Year of publication | 2021 |
Type | Appeared in Conference without Proceedings |
MU Faculty or unit | |
Citation | |
Description | The global prevalence of insomnia symptoms is between 30-35% and the course of the disease is often chronic (Morin et al., 2015). Clinically significant insomnia is reported by 10–23% of college students (Gress-Smith et al., 2015). The European Guideline for the Diagnosis and Treatment of Insomnia, developed by a working group of the European Society for Sleep Research, proposes cognitive behavioral therapy for insomnia as paramount in the treatment of chronic insomnia in adults of any age (Riemann et al., 2017).The aim of the first part of research project is the translation and adaptation of the Insomnia Type Questionnaire (Blanken et al., 2019) into the Czech sociocultural environment and subsequent verification of its psychometric characteristics and mapping of subtypes of insomnia in the population of young adults. In addition to the Insomnia Type Questionnaire, the test battery contains the questionnaires needed to validate the scales (PSQI, Zung Self-Rating Depression Scale (SDS), Zung Self-Rating Anxiety Scale (SAS), BFI). In second part of study, the aim is to verify the effectiveness of cognitive behavioral therapy of insomnia (CBT-I). We are interested in whether the classification of subjects in research according to subtypes created by Blanken et al. (2019) will correlate with the effectiveness of CBT-I intervention. The research set is composed of university students. The expected number of participants for the CBT-I intervention is 60 students. The planned CBT-I group intervention will take place in a group of approximately 10 students. Two parallel CBT-I groups will take place for three semesters. A control group is not considered in the study. The identification of insomnia subtypes is a potential benefit for clinical practice, as it could allow the selection of high-risk individuals for early preventive intervention. Reducing previously unrecognized insomnia heterogeneity through subtyping can then help elucidate the mechanisms of insomnia and the development of personalized insomnia treatment. |
Related projects: |